4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-16-122115
Director bought 15,000 shares at $1.56 ($23,400)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sigal Charles Elliott Director | 2016-05-19 | Purchase | +15,000 | $1.56 | $23,400 | 314,100 | I |
| Open-market purchases · 15,000 sh · avg $1.56 · $23,400 | |||||||
Loading xslF345X03/a4.xml…